The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Open accessAbstract
We herein present an overview of the upcoming 5 th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4 th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5 th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Self-citationHallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-093906 · Cited by 3,787
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Self-citationBreitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., & Förster, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1545 · Cited by 1,464
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Willemze, R., Cerroni, L., Kempf, W., Berti, E., Facchetti, F., Swerdlow, S. H., & Jaffe, E. S. (2019) · Blood · doi:10.1182/blood-2018-11-881268 · Cited by 1,412
Self-citationGreen, M. R., Monti, S., Rodig, S. J., Juszczynski, P., Currie, T., O'Donnell, E., Chapuy, B., Takeyama, K., Neuberg, D., Golub, T. R., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282780 · Cited by 1,305
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,294
Self-citationTangye, S. G., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00737-x · Cited by 1,210
Wright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Genetic and functional drivers of diffuse large B cell lymphoma
Reddy, A., Zhang, J., Davis, N. S., Moffitt, A. B., Love, C. L., Waldrop, A., Leppa, S., Pasanen, A., Meriranta, L., Karjalainen-Lindsberg, M.-L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.027 · Cited by 1,104
Integrated molecular analysis of adult T cell leukemia/lymphoma
Kataoka, K., Nagata, Y., Kitanaka, A., Shiraishi, Y., Shimamura, T., Yasunaga, J.-I., Totoki, Y., Chiba, K., Sato-Otsubo, A., Nagae, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3415 · Cited by 794
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, M. G. M., Advani, R. H., Ligon, A. H., Natkunam, Y., Redd, R. A., Homer, H., Connelly, C. F., Sun, H. H., Daadi, S. E., Freeman, G. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.4482 · Cited by 791
Self-citationRajkumar, S. V., Kyle, R. A., Therneau, T. M., Melton, L. J., Bradwell, A. R., Clark, R. J., Larson, D. R., Plevak, M. F., Dispenzieri, A., & Katzmann, J. A. (2005) · Blood · doi:10.1182/blood-2005-03-1038 · Cited by 702
Self-citationBennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R., & Sultan, C. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.6.567 · Cited by 694
(2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30029-8 · Cited by 672
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
Sakata-Yanagimoto, M., Enami, T., Yoshida, K., Shiraishi, Y., Ishii, R., Miyake, Y., Muto, H., Tsuyama, N., Sato-Otsubo, A., Okuno, Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.2872 · Cited by 651
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Kataoka, K., Shiraishi, Y., Takeda, Y., Sakata, S., Matsumoto, M., Nagano, S., Maeda, T., Nagata, Y., Kitanaka, A., Mizuno, S., et al. (2016) · Nature · doi:10.1038/nature18294 · Cited by 651
Fajgenbaum, D. C., Uldrick, T. S., Bagg, A., Frank, D., Wu, D., Srkalovic, G., Simpson, D., Liu, A. Y., Menke, D., Chandrakasan, S., et al. (2017) · Blood · doi:10.1182/blood-2016-10-746933 · Cited by 648
Self-citationde Leval, L., Rickman, D. S., Thielen, C., Reynies, A. D., Huang, Y.-L., Delsol, G., Lamant, L., Leroy, K., Brière, J., Molina, T., et al. (2007) · Blood · doi:10.1182/blood-2006-10-055145 · Cited by 631
Self-citationPAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Gu, Z., Churchman, M. L., Roberts, K. G., Moore, I., Zhou, X., Nakitandwe, J., Hagiwara, K., Pelletier, S., Gingras, S., Berns, H., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0315-5 · Cited by 603
Self-citationIqbal, J., Wright, G., Wang, C., Rosenwald, A., Gascoyne, R. D., Weisenburger, D. D., Greiner, T. C., Smith, L., Guo, S., Wilcox, R. A., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536359 · Cited by 552
Self-citationLeung, N., Bridoux, F., Batuman, V., Chaidos, A., Cockwell, P., D’Agati, V. D., Dispenzieri, A., Fervenza, F. C., Fermand, J.-P., Gibbs, S., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0077-4 · Cited by 551
Self-citationKim, J. H., Kim, J. W., Kim, Y. N., Kim, H. I., Kim, J. Y., Kwon, G. Y., Kim, K., & Jang, H. R. (2015) · Case Reports in Nephrology and Dialysis · doi:10.1159/000439267 · Cited by 538
Harris, N. L. (1995) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(00)80051-4 · Cited by 527
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
Cairns, R. A., Iqbal, J., Lemonnier, F., Kucuk, C., de Leval, L., Jais, J.-P., Parrens, M., Martin, A., Xerri, L., Brousset, P., et al. (2012) · Blood · doi:10.1182/blood-2011-11-391748 · Cited by 509
Self-citationHunter, Z. R., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Manning, R. J., Tripsas, C., Patterson, C. J., Sheehy, P., et al. (2014) · Blood · doi:10.1182/blood-2013-09-525808 · Cited by 488
Roberts, K. G., Gu, Z., Payne-Turner, D., McCastlain, K., Harvey, R. C., Chen, I.-M., Pei, D., Iacobucci, I., Valentine, M., Pounds, S. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.0073 · Cited by 453
Kimura, H., Ito, Y., Kawabe, S., Gotoh, K., Takahashi, Y., Kojima, S., Naoe, T., Esaki, S., Kikuta, A., Sawada, A., et al. (2012) · Blood · doi:10.1182/blood-2011-10-381921 · Cited by 448
Self-citationDiagnosis of monoclonal gammopathy of renal significance
Bridoux, F., on behalf of the International Kidney and Monoclonal Gammopathy Research Group, Leung, N., Hutchison, C. A., Touchard, G., Sethi, S., Fermand, J.-P., Picken, M. M., Herrera, G. A., Kastritis, E., et al. (2015) · Kidney International · doi:10.1038/ki.2014.408 · Cited by 426
Self-citationEnnishi, D., Jiang, A., Boyle, M., Collinge, B., Grande, B. M., Ben-Neriah, S., Rushton, C., Tang, J., Thomas, N., Slack, G. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01583 · Cited by 414
Diagnostic criteria for monoclonal B‐cell lymphocytosis
Marti, G. E., Rawstron, A. C., Ghia, P., Hillmen, P., Houlston, R. S., Kay, N., Schleinitz, T. A., Caporaso, N., & The International Familial CLL Consortium (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05550.x · Cited by 412
Self-citationBreast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Miranda, R. N., Aladily, T. N., Prince, H. M., Kanagal-Shamanna, R., de Jong, D., Fayad, L. E., Amin, M. B., Haideri, N., Bhagat, G., Brooks, G. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.7911 · Cited by 405
Self-citationA targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Odejide, O., Weigert, O., Lane, A. A., Toscano, D., Lunning, M. A., Kopp, N., Kim, S., van Bodegom, D., Bolla, S., Schatz, J. H., et al. (2014) · Blood · doi:10.1182/blood-2013-10-531509 · Cited by 398
Self-citationChronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
Hallek, M., & Al‐Sawaf, O. (2021) · American Journal of Hematology · doi:10.1002/ajh.26367 · Cited by 393
Treon, S. P., Cao, Y., Xu, L., Yang, G., Liu, X., & Hunter, Z. R. (2014) · Blood · doi:10.1182/blood-2014-01-550905 · Cited by 388
Dorfman, D. M., Brown, J. A., Shahsafaei, A., & Freeman, G. J. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000209855.28282.ce · Cited by 358
Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10
Attygalle, A. D., Al-Jehani, R. M., Diss, T. C., Munson, P., Liu, H., Du, M., Isaacson, P. G., & Doǧan, A. (2002) · Blood · doi:10.1182/blood.v99.2.627 · Cited by 353
Self-citationFan, Z., Natkunam, Y., Bair, E., Tibshirani, R., & Warnke, R. A. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200310000-00007 · Cited by 344
Self-citationOncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Song, T. L., Nairismägi, M.-L., Laurensia, Y., Lim, J.-Q., Tan, J., Li, Z.-M., Pang, W.-L., Kizhakeyil, A., Wijaya, G.-C., Huang, D.-C., et al. (2018) · Blood · doi:10.1182/blood-2018-01-829424 · Cited by 326
Self-citationSwiecicki, P. L., Hegerova, L. T., & Gertz, M. A. (2013) · Blood · doi:10.1182/blood-2013-02-474437 · Cited by 324
Vallois, D., Dobay, M. P. D., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B., Roberti, A., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698977 · Cited by 324
Orchard, J. A., Garand, R., Davis, Z. A., Babbage, G., Sahota, S. S., Matutes, E., Catovsky, D., Thomas, P., Avet‐Loiseau, H., & Oscier, D. G. (2003) · Blood · doi:10.1182/blood-2002-06-1864 · Cited by 320
Lilljebjörn, H., Henningsson, R., Hyrenius-Wittsten, A., Olsson, L., Orsmark-Pietras, C., von Palffy, S., Askmyr, M., Rissler, M., Schrappe, M., Cario, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11790 · Cited by 314
KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma
Chadburn, A., Hyjek, E., Mathew, S., Cesarman, E., Said, J., & Knowles, D. M. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000138177.10829.5c · Cited by 312
Self-citationTNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Honma, K., Tsuzuki, S., Nakagawa, M., Tagawa, H., Nakamura, S., Morishima, Y., & Seto, M. (2009) · Blood · doi:10.1182/blood-2008-12-194852 · Cited by 305
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group
Reshmi, S. C., Harvey, R. C., Roberts, K. G., Stonerock, E., Smith, A., Jenkins, H., Chen, I.-M., Valentine, M., Liu, Y., Li, Y., et al. (2017) · Blood · doi:10.1182/blood-2016-12-758979 · Cited by 302
Self-citationSha, C., Barrans, S., Cucco, F., Bentley, M. A., Care, M. A., Cummin, T., Kennedy, H., Thompson, J. S., Uddin, R., Worrillow, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01314 · Cited by 300
Self-citationBi, X.-W., Wang, H., Zhang, W.-W., Wang, J.-H., Liu, W.-J., Xia, Z.-J., Huang, H.-Q., Jiang, W.-Q., Zhang, Y.-J., & Wang, L. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0341-7 · Cited by 297
Self-citationSalaverria, I., Philipp, C., Oschlies, I., Kohler, C. W., Kreuz, M., Szczepanowski, M., Burkhardt, B., Trautmann, H., Gesk, S., Andrusiewicz, M., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330795 · Cited by 292
Self-citationGenomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Gu, Z., Churchman, M., Roberts, K., Li, Y., Liu, Y., Harvey, R. C., McCastlain, K., Reshmi, S. C., Payne-Turner, D., Iacobucci, I., et al. (2016) · Nature Communications · doi:10.1038/ncomms13331 · Cited by 290
Self-citationGenomic landscape and chronological reconstruction of driver events in multiple myeloma
Maura, F., Bolli, N., Angelopoulos, N., Dawson, K. J., Leongamornlert, D., Martincorena, I., Mitchell, T. J., Fullam, A., Gonzalez, S., Szalat, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11680-1 · Cited by 278
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Heavican, T. B., Bouska, A., Yu, J., Lone, W., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., et al. (2019) · Blood · doi:10.1182/blood-2018-09-872549 · Cited by 275
Self-citationGrande, B. M., Gerhard, D. S., Jiang, A., Griner, N. B., Abramson, J. S., Alexander, T. B., Allen, H., Ayers, L. W., Bethony, J. M., Bhatia, K., et al. (2019) · Blood · doi:10.1182/blood-2018-09-871418 · Cited by 270
Self-citationRecurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Yasuda, T., Tsuzuki, S., Kawazu, M., Hayakawa, F., Kojima, S., Ueno, T., Imoto, N., Kohsaka, S., Kunita, A., Doi, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3535 · Cited by 265
Unique gene expression program of human germinal center T helper cells
Kim, C. H., Lim, H. W., Kim, J. R., Rott, L., Hillsamer, P., & Butcher, E. C. (2004) · Blood · doi:10.1182/blood-2004-03-1206 · Cited by 257
Fischer, U., Forster, M., Rinaldi, A., Risch, T., Sungalee, S., Warnatz, H.-J., Bornhauser, B., Gombert, M., Kratsch, C., Stütz, A. M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3362 · Cited by 257
Navarro, A., Clot, G., Royo, C., Jares, P., Hadzidimitriou, A., Agathangelidis, A., Bikos, V., Darzentas, N., Papadaki, T., Salaverria, I., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1615 · Cited by 256
Self-citationChronic lymphocytic leukaemia: from genetics to treatment
Bosch, F., & Dalla-Favera, R. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0239-8 · Cited by 242
Gérard, L., Bérezné, A., Galicier, L., Meignin, V., Obadia, M., De Castro, N., Jacomet, C., Verdon, R., Madelaine-Chambrin, I., Boulanger, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6732 · Cited by 235
Hirabayashi, S., Ohki, K., Nakabayashi, K., Ichikawa, H., Momozawa, Y., Okamura, K., Yaguchi, A., Terada, K., Saito, Y., Yoshimi, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.151035 · Cited by 235
Dobay, M. P., Lemonnier, F., Missiaglia, E., Bastard, C., Vallois, D., Jais, J.-P., Scourzic, L., Dupuy, A., Fataccioli, V., Pujals, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.158428 · Cited by 231
Self-citationRiemersma, S. A., Jordanova, E. S., Schop, R. F. J., Philippo, K., Looijenga, L. H. J., Schuuring, E., & Kluin, P. M. (2000) · Blood · doi:10.1182/blood.v96.10.3569 · Cited by 227
Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome
Lim, M. S., Straus, S. E., Dale, J. K., Fleisher, T. A., Stetler-Stevenson, M., Strober, W., Sneller, M. C., Puck, J. M., Lenardo, M. J., Elenitoba-Johnson, K. S. J., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65742-2 · Cited by 222
Self-citationNadeu, F., Martin-Garcia, D., Clot, G., Díaz-Navarro, A., Duran-Ferrer, M., Navarro, A., Vilarrasa-Blasi, R., Kulis, M., Royo, R., Gutiérrez-Abril, J., et al. (2020) · Blood · doi:10.1182/blood.2020005289 · Cited by 210
Self-citationLi, J., Gaillard, F., Moreau, A., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65399-0 · Cited by 207
CCND2 rearrangements are the most frequent genetic events in cyclin D1− mantle cell lymphoma
Salaverria, I., Royo, C., Carvajal-Cuenca, A., Clot, G., Navarro, A., Valera, A., Song, J. Y., Woroniecka, R., Rymkiewicz, G., Klapper, W., et al. (2013) · Blood · doi:10.1182/blood-2012-08-452284 · Cited by 201
Self-citationIndolent T-cell lymphoproliferative disease of the gastrointestinal tract
Perry, A. M., Warnke, R. A., Hu, Q., Gaulard, P., Copie-Bergman, C., Alkan, S., Wang, H.-Y., Cheng, J. X., Bacon, C. M., Delabie, J., et al. (2013) · Blood · doi:10.1182/blood-2013-07-512830 · Cited by 198
Watatani, Y., Sato, Y., Miyoshi, H., Sakamoto, K., Nishida, K., Gion, Y., Nagata, Y., Shiraishi, Y., Chiba, K., Tanaka, H., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0473-1 · Cited by 195
Hartmann, S., Eichenauer, D. A., Plütschow, A., Mottok, A., Bob, R., Koch, K., Bernd, H.-W., Cogliatti, S., Hummel, M., Feller, A. C., et al. (2013) · Blood · doi:10.1182/blood-2013-07-515825 · Cited by 192
Self-citationRinaldi, A., Mian, M., Chigrinova, E., Arcaini, L., Bhagat, G., Novak, U., Rancoita, P. M. V., De Campos, C. P., Forconi, F., Gascoyne, R. D., et al. (2011) · Blood · doi:10.1182/blood-2010-01-264275 · Cited by 190
Self-citationThe whole-genome landscape of Burkitt lymphoma subtypes
Panea, R. I., Love, C. L., Shingleton, J. R., Reddy, A., Bailey, J. A., Moormann, A. M., Otieno, J. A., Ong’echa, J. M., Oduor, C. I., Schroeder, K. M. S., et al. (2019) · Blood · doi:10.1182/blood.2019001880 · Cited by 186
Self-citationBCL10 Expression in Normal and Neoplastic Lymphoid Tissue
Ye, H., Doǧan, A., Karran, L., Willis, T. G., Chen, L., Włodarska, I., Dyer, M. J. S., Isaacson, P. G., & Du, M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64630-5 · Cited by 182
Self-citationHadzidimitriou, A., Agathangelidis, A., Darzentas, N., Murray, F., Delfau-Larue, M.-H., Pedersen, L. B., Lopez, A. N., Dagklis, A., Rombout, P., Beldjord, K., et al. (2011) · Blood · doi:10.1182/blood-2011-03-343434 · Cited by 181
Self-citationFate mapping reveals origin and dynamics of lymph node follicular dendritic cells
Jarjour, M., Jorquera, A., Mondor, I., Wienert, S., Narang, P., Coles, M. C., Klauschen, F., & Bajénoff, M. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132409 · Cited by 180
Mansoor, A., Pittaluga, S., Beck, P. L., Wilson, W. H., Ferry, J. A., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2010-08-302737 · Cited by 179
Self-citationThe Genetic Landscape of Diffuse Large B-Cell Lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.005 · Cited by 178
The genetics of nodal marginal zone lymphoma
Spina, V., Khiabanian, H., Messina, M., Monti, S., Cascione, L., Bruscaggin, A., Spaccarotella, E., Holmes, A. B., Arcaini, L., Lucioni, M., et al. (2016) · Blood · doi:10.1182/blood-2016-02-696757 · Cited by 177
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Berentsen, S., Barcellini, W., D’Sa, S., Randen, U., Tvedt, T. H. A., Fattizzo, B., Haukås, E., Kell, M., Brudevold, R., Dahm, A. E. A., et al. (2020) · Blood · doi:10.1182/blood.2020005674 · Cited by 176
Amador, C., Greiner, T. C., Heavican, T. B., Smith, L. M., Galvis, K. T., Lone, W., Bouska, A., D’Amore, F., Pedersen, M. B., Pileri, S., et al. (2019) · Blood · doi:10.1182/blood.2019000779 · Cited by 175
Self-citationZamagni, E., Nanni, C., Dozza, L., Carlier, T., Bailly, C., Tacchetti, P., Versari, A., Chauvie, S., Gallamini, A., Gamberi, B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00386 · Cited by 175
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
Abate, F., Ambrosio, M. R., Mundo, L., Laginestra, M. A., Fuligni, F., Rossi, M., Zairis, S., Gazaneo, S., De Falco, G., Lazzi, S., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005158 · Cited by 171
Self-citationStaber, P. B., Herling, M., Bellido, M., Jacobsen, E. D., Davids, M. S., Kadia, T. M., Shustov, A., Tournilhac, O., Bachy, E., Zaja, F., et al. (2019) · Blood · doi:10.1182/blood.2019000402 · Cited by 165
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Treon, S. P., Xu, L., Guerrera, M. L., Jimenez, C., Hunter, Z. R., Liu, X., Demos, M., Gustine, J., Chan, G., Munshi, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02314 · Cited by 165
Human follicular dendritic cells: function, origin and development
van Nierop, K. (2002) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00057-x · Cited by 163
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Condoluci, A., di Bergamo, L. T., Langerbeins, P., Hoechstetter, M. A., Herling, C., Paoli, L. D., Delgado, J., Rabe, K. G., Gentile, M., Doubek, M., et al. (2020) · Blood · doi:10.1182/blood.2019003453 · Cited by 163
Attygalle, A. D., Cabeçadas, J., Gaulard, P., Jaffe, E. S., de Jong, D., Ko, Y. H., Said, J., & Klapper, W. (2014) · Histopathology · doi:10.1111/his.12251 · Cited by 162
Self-citationShanafelt, T. D., Kay, N. E., Rabe, K. G., Call, T. G., Zent, C. S., Maddocks, K. J., Jenkins, G. D., Jelinek, D. F., Morice, W. G., Boysen, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2704 · Cited by 159
Self-citationPrognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma
Kataoka, K., Iwanaga, M., Yasunaga, J.-I., Nagata, Y., Kitanaka, A., Kameda, T., Yoshimitsu, M., Shiraishi, Y., Sato-Otsubo, A., Sanada, M., et al. (2018) · Blood · doi:10.1182/blood-2017-01-761874 · Cited by 159
Roncador, G., Verdes-Montenegro, J. F. G., Tedoldi, S., Paterson, J. C., Klapper, W., Ballabio, E., Maestre, L., Pileri, S. A., Hansmann, M.-L., Piris, M. A., et al. (2007) · Haematologica · doi:10.3324/haematol.10864 · Cited by 157
Self-citationCounting mitoses: SI(ze) matters!
Cree, I. A., Tan, P. H., Travis, W. D., Wesseling, P., Yagi, Y., White, V. A., Lokuhetty, D., & Scolyer, R. A. (2021) · Modern Pathology · doi:10.1038/s41379-021-00825-7 · Cited by 156
Ye, H., Gong, L., Liu, H., Hamoudi, R., Shirali, S., Ho, L. K. F., Chott, A., Streubel, B., Siebert, R., Gesk, S., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1715 · Cited by 155
Self-citationKatzenberger, T., Kalla, J., Leich, E., Stöcklein, H., Hartmann, E., Barnickel, S., Weßendorf, S., Ott, M. M., Müller‐Hermelink, H. K., Rosenwald, A., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168682 · Cited by 155
Self-citationUldrick, T. S., Polizzotto, M. N., Aleman, K. O., O’Mahony, D., Wyvill, K. M., Wang, V., Marshall, V. A., Pittaluga, S., Steinberg, S. M., Tosato, G., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317610 · Cited by 152
Blombery, P. A., Thompson, E. R., Jones, K. L., Arnau, G. M., Lade, S., Markham, J. F., Li, J., Deva, A. K., Johnstone, R. W., Khot, A. S., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.146118 · Cited by 150
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P. H., et al. (2017) · Blood · doi:10.1182/blood-2016-12-755496 · Cited by 148
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., et al. (2020) · Blood · doi:10.1182/blood.2020007247 · Cited by 146
Laurent, C., Nicolae, A., Laurent, C., Bras, F. L., Haïoun, C., Fataccioli, V., Amara, N., Adélaïde, J., Guillé, A., Schiano, J.-M., et al. (2019) · Blood · doi:10.1182/blood.2019001904 · Cited by 141
Self-citationDufva, O., Kankainen, M., Kelkka, T., Sekiguchi, N., Awad, S. A., Eldfors, S., Yadav, B., Kuusanmäki, H. A., Malani, D., Andersson, E. I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03987-2 · Cited by 137
Self-citationTanasi, I., Ba, I., Sirvent, N., Braun, T., Cuccuini, W., Ballerini, P. F., Duployez, N., Schmidt, A., Tamburini, J., Maury, S., et al. (2019) · Blood · doi:10.1182/blood.2019001244 · Cited by 137
Cavo, M., Miguel, J. F. S., Usmani, S. Z., Weisel, K. C., Dimopoulos, M. A., Avet‐Loiseau, H., Paiva, B., Bahlis, N. J., Plesner, T., Hungria, V., et al. (2021) · Blood · doi:10.1182/blood.2021011101 · Cited by 133
Self-citationNg, S., Chung, T., Kato, S. X., Nakamura, S., Takahashi, E., Ko, Y. H., Khoury, J. D., Yin, C. C., Soong, R., Jeyasekharan, A. D. D., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.180430 · Cited by 130
Self-citationBoyle, E. M., Deshpande, S., Tytarenko, R., Ashby, C., Wang, Y., Bauer, M. A., Johnson, S. K., Wardell, C. P., Thanendrarajan, S., Zangari, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20524-2 · Cited by 128
Marafioti, T., Paterson, J. C., Ballabio, E., Chott, A., Natkunam, Y., Rodriguez‐Justo, M., Plonquet, A., Rodríguez-Pinilla, S. M., Klapper, W., Hansmann, M. L., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.010991 · Cited by 128
Self-citationMoreira, J., Rabe, K. G., Cerhan, J. R., Kay, N. E., Wilson, J. W., Call, T. G., Leis, J. F., Jelinek, D. F., Schwager, S. M., Bowen, D. A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.187 · Cited by 128
The complex landscape of genetic alterations in mantle cell lymphoma
Royo, C., Salaverría, I., Hartmann, E., Rosenwald, A., Campo, E., & Beà, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.007 · Cited by 126
Self-citationScarfò, I., Pellegrino, E., Mereu, E., Kwee, I., Agnelli, L., Bergaggio, E., Garaffo, G., Vitale, N., Caputo, M., Machiorlatti, R., et al. (2015) · Blood · doi:10.1182/blood-2014-12-614503 · Cited by 124
KSHV/HHV8-mediated hematologic diseases
Cesarman, E., Chadburn, A., & Rubinstein, P. G. (2021) · Blood · doi:10.1182/blood.2020005470 · Cited by 124
Self-citationSwerdlow, S. H., Kuzu, I., Doǧan, A., Dirnhofer, S., Chan, J. K. C., Sander, B., Ott, G., Xerri, L., Quintanilla‐Martínez, L., & Campo, E. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1858-9 · Cited by 122
Self-citationChanudet, E., Ye, H., Ferry, J. A., Bacon, C. M., Adam, P., Müller-Hermelink, H. K., Radford, J. A., Pileri, S., Ichimura, K., Collins, V. P., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2466 · Cited by 122
Self-citationMorphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
King, R. L., Dao, L. N., McPhail, E. D., Jaffe, E. S., SAID, J. W., Swerdlow, S. H., Sattler, C. A., Ketterling, R. P., Sidhu, J. S., Hsi, E. D., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000500 · Cited by 122
Self-citationBiologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
Iacobucci, I., Kimura, S., & Mullighan, C. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173792 · Cited by 121
Kaymaz, Y., Oduor, C. I., Yu, H., Otieno, J. A., Ong'echa, J. M., Moormann, A. M., & Bailey, J. A. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0305 · Cited by 120
Napoli, A. D., Jain, P., Duranti, E., Margolskee, E. M., Arancio, W., Facchetti, F., Alobeid, B., di Pompeo, F. S., MANSUKHANI, M. M., & Bhagat, G. (2016) · British Journal of Haematology · doi:10.1111/bjh.14431 · Cited by 120
Self-citationKSHV/HHV8-negative Effusion-based Lymphoma, a Distinct Entity Associated With Fluid Overload States
Alexanian, S., SAID, J. W., Lones, M. A., & Pullarkat, S. T. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318267fabc · Cited by 119
Self-citationPRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
Boi, M., Rinaldi, A., Kwee, I., Bonetti, P., Todaro, M., Tabbò, F., Piva, R., Rancoita, P. M. V., Matolcsy, A., Tímár, B., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497933 · Cited by 119
Self-citationNumerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas.
Brynes, R. K., Almaguer, P. D., Leathery, K. E., McCourty, A., Arber, D. A., Medeiros, L. J., & Nathwani, B. N. (1996) · PubMed · Cited by 118
Self-citationFollicular lymphoma t(14;18)-negative is genetically a heterogeneous disease
Nann, D., Ramis-Zaldivar, J. E., Müller, I., González‐Farré, B., Schmidt, J., Egan, C., Salmerón‐Villalobos, J., Clot, G., Mattern, S., Otto, F., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002944 · Cited by 118
Self-citationCucco, F., Barrans, S., Sha, C., Clipson, A., Crouch, S., Dobson, R. C., Chen, Z., Thompson, J. S., Care, M. A., Cummin, T., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0691-6 · Cited by 116
Self-citationHunter, Z. R., Xu, L., Yang, G., Tsakmaklis, N., Vos, J. M. I., Liu, X., Chen, J., Manning, R. J., Chen, J. G., Brodsky, P., et al. (2016) · Blood · doi:10.1182/blood-2016-03-708263 · Cited by 115
Mutational landscape of gray zone lymphoma
Sarkozy, C., Hung, S. S., Chavez, E. A., Duns, G., Takata, K., Chong, L. C., Aoki, T., Jiang, A., Miyata‐Takata, T., Telenius, A., et al. (2020) · Blood · doi:10.1182/blood.2020007507 · Cited by 112
Self-citationAllday, M. J. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.007 · Cited by 111
Rawstron, A. C., Shanafelt, T. D., Lanasa, M. C., Landgren, O., Hanson, C. A., Órfão, A., Hillmen, P., & Ghia, P. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20533 · Cited by 110
Self-citationWhole-genome landscape of adult T-cell leukemia/lymphoma
Kogure, Y., Kameda, T., Koya, J., Yoshimitsu, M., Nosaka, K., Yasunaga, J., Imaizumi, Y., Watanabe, M., Saito, Y., Ito, Y., et al. (2021) · Blood · doi:10.1182/blood.2021013568 · Cited by 107
Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
van der Harst, E., Bruining, H. A., Bonjer, H. J., van der Ham, F., Dinjens, W. N. M., Lamberts, S. W. J., de Herder, W. W., Koper, J. W., Stijnen, T., Proye, C. A. G., et al. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200006)191:2<217::aid-path586>3.0.co;2-6 · Cited by 105
Wagener, R., Seufert, J., Raimondi, F., Bens, S., Kleinheinz, K., Nagel, I., Altmüller, J., Thiele, H., Hübschmann, D., Kohler, C. W., et al. (2018) · Blood · doi:10.1182/blood-2018-07-864025 · Cited by 104
Self-citationSharma, A., Oishi, N., Boddicker, R. L., Hu, G., Benson, H. K., Ketterling, R. P., Greipp, P. T., Knutson, D. L., Kloft‐Nelson, S. M., He, R. L., et al. (2018) · Blood · doi:10.1182/blood-2018-01-830968 · Cited by 102
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
Bardelli, V., Arniani, S., Pierini, V., Giacomo, D. D., Pierini, T., Gorello, P., Mecucci, C., & Starza, R. L. (2021) · Genes · doi:10.3390/genes12081118 · Cited by 101
Huang, L., Liu, D., Wang, N., Ling, S., Tang, Y., Wu, J., Hao, L., Luo, H., Hu, X., Sheng, L., et al. (2017) · Cell Research · doi:10.1038/cr.2017.146 · Cited by 100
Lim, J. Q., Huang, D., Tang, T. P. L., Tan, D. C. L., Laurensia, Y., Peng, R., Wong, E. K. Y., Cheah, D. M. Z., Chia, B. K. H., Iqbal, J., et al. (2020) · Leukemia · doi:10.1038/s41375-020-1000-0 · Cited by 91
Self-citationPasset, M., Boissel, N., Sigaux, F., Saillard, C., Bargetzi, M. J., Ba, I., Thomas, X., Graux, C., Chalandon, Y., Leguay, T., et al. (2018) · Blood · doi:10.1182/blood-2018-10-882142 · Cited by 88
Chadburn, A., SAID, J. W., Gratzinger, D. A., Chan, J. K. C., de Jong, D., Jaffe, E. S., Natkunam, Y., & Goodlad, J. R. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw218 · Cited by 87
Self-citationWai, C. M. M., Chen, S., Phyu, T., Fan, S., Leong, S. M., Zheng, W., Low, L. C. Y., Choo, S., Lee, C.-K., Chung, T., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280003 · Cited by 87
Self-citationPrognostic Factors of Hepatosplenic T-cell Lymphoma
Yabe, M., Medeiros, L. J., Tang, G., Wang, S. A., Ahmed, S., Nieto, Y. L., Hu, S., Bhagat, G., Oki, Y., Patel, K. P., et al. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000614 · Cited by 86
Self-citationVela, V., Juškevičius, D., Dirnhofer, S., Menter, T., & Tzankov, A. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03186-3 · Cited by 86
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, M. G. M., Advani, R. H., Ligon, A. H., Natkunam, Y., Redd, R. A., Homer, H., Connelly, C. F., Sun, H. H., Daadi, S. E., Chapuy, B., et al. (2015) · Blood · doi:10.1182/blood.v126.23.176.176 · Cited by 85
Self-citationGenomics of Hairy Cell Leukemia
Tiacci, E., Pettirossi, V., Schiavoni, G., & Falini, B. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.1556 · Cited by 83
Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
Chau, I., Jones, R. L., Cunningham, D., Wotherspoon, A. C., Maisey, N. R., Norman, A. R., Jain, P., Bishop, L., Horwich, A., & Catovsky, D. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601006 · Cited by 82
Current treatment options in hairy cell leukemia and hairy cell leukemia variant
Robak, T. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.04.010 · Cited by 81
Soderquist, C. R., Patel, N., Murty, V. V. V. S., Betman, S., Aggarwal, N., Young, K. H., Xerri, L., Leeman‐Neill, R. J., Lewis, S. K., Green, P. H., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.230961 · Cited by 81
Self-citationSiddiqi, I. N., Friedman, J., Barry-Holson, K. Q., Ma, C., Thodima, V. J., Kang, I. M., Padmanabhan, R., Dias, L. M., Kelly, K. R., Brynes, R. K., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.51 · Cited by 80
Hartmann, S., Döring, C., Vucic, E. A., Chan, F. C., Ennishi, D., Tousseyn, T., Wolf‐Peeters, C. D., Perner, S., Włodarska, I., Steidl, C., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13310 · Cited by 76
Self-citationHigh-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations
Pillonel, V., Juškevičius, D., Ng, C. K. Y., Bodmer, A., Zettl, A., Jucker, D., Dirnhofer, S., & Tzankov, A. (2018) · Leukemia · doi:10.1038/s41375-018-0082-4 · Cited by 75
Ramaswami, R., Lurain, K. A., Polizzotto, M. N., Ekwede, I., Waldon, K., Steinberg, S. M., Mangusan, R., Widell, A., Rupert, A. W., George, J. M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004058 · Cited by 75
Nováková, M., Zaliova, M. K., Fišer, K., Vakrmanová, B., Slámová, L., Musilová, A., Brüggemann, M., Ritgen, M., Froňková, E., Kalina, T., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.250423 · Cited by 74
Jones, C. L., Degasperi, A., Grandi, V., Amarante, T. D., Ambrose, J. C., Arumugam, P., Baple, E. L., Bleda, M., Boardman-Pretty, F., Boissiere, J. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83352-4 · Cited by 73
IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
Wagener, R., López, C., Kleinheinz, K., Bausinger, J., Aukema, S., Nagel, I., Toprak, U. H., Seufert, J., Altmüller, J., Thiele, H., et al. (2018) · Blood · doi:10.1182/blood-2018-03-842088 · Cited by 72
Self-citationKlomjit, N., Leung, N., Fervenza, F. C., Sethi, S. M., & Zand, L. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010054 · Cited by 71
Self-citationCD371 cell surface expression: a unique feature of DUX4 -rearranged acute lymphoblastic leukemia
Schinnerl, D., Mejstříková, E., Schumich, A., Zaliova, M. K., Fortschegger, K., Nebral, K., Attarbaschi, A., Fišer, K., Kauer, M. O., Popitsch, N. P., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.214353 · Cited by 70
Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
Tang, Y.-T., Wang, D., Luo, H., Xiao, M., Zhou, H.-S., Liu, D., Ling, S.-P., Wang, N., Hu, X.-L., Luo, Y., et al. (2017) · Blood Cancer Journal · doi:10.1038/s41408-017-0021-z · Cited by 67
Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma
Maurus, K., Appenzeller, S., Roth, S., Kuper, J., Rost, S., Meierjohann, S., Arampatzi, P., Goebeler, M., Rosenwald, A., Geissinger, E., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.015 · Cited by 67
Self-citationHormann, F. M., Hoogkamer, A. Q., Beverloo, H. B., Boeree, A., Dingjan, I., Wattel, M. M., Stam, R. W., Escherich, G., Pieters, R., den Boer, M. L., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.206961 · Cited by 67
Schuhmacher, B., Bein, J., Rausch, T., Beneš, V., Tousseyn, T., Vornanen, M., Ponzoni, M., Thurner, L., Gascoyne, R. D., Steidl, C., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.203224 · Cited by 65
Self-citationc-Maf Expression in Angioimmunoblastic T-cell Lymphoma
Murakami, Y., Yatabe, Y., Sakaguchi, T., Sasaki, E., Yamashita, Y., Morito, N., Yoh, K., Fujioka, Y., Matsuno, F., Hata, H., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318054dbcf · Cited by 63
Sykes, D. B., O'Connell, C. L., & Schroyens, W. (2020) · Blood · doi:10.1182/blood.2019004216 · Cited by 63
Dorfman, D. M., & Shahsafaei, A. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31820065c9 · Cited by 58
Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma
Vries, G. T. L.-D., de Boer, M., van Dijk, E., Stathi, P., Hijmering, N. J., Roemer, M. G. M., Mendeville, M., Miedema, D. M., de Boer, J. P., Rakhorst, H. A., et al. (2020) · Blood · doi:10.1182/blood.2020005372 · Cited by 58
Immunosenescence and lymphomagenesis
Mancuso, S., Carlisi, M., Santoro, M., Napolitano, M., Raso, S., & Siragusa, S. M. (2018) · Immunity & Ageing · doi:10.1186/s12979-018-0130-y · Cited by 57
Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia
Teramo, A., Barilà, G., Calabretto, G., Vicenzetto, C., Gasparini, V. R., Semenzato, G., & Zambello, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00152 · Cited by 57
Alame, M., Cornillot, E., Cacheux, V., Rigau, V., Costes‐Martineau, V., Szablewski, V., & Colinge, J. (2021) · Theranostics · doi:10.7150/thno.54343 · Cited by 57
Richter, J., John, K., Staiger, A. M., Rosenwald, A., Kurz, K. S., Michgehl, U., Ott, G., Franzenburg, S., Kohler, C., Finger, J., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17874 · Cited by 56
Self-citationShanafelt, T. D., Kay, N. E., Parikh, S. A., Achenbach, S. J., Lesnick, C. E., Hanson, C. A., Kleinstern, G., Olson, J. E., Norman, A. D., Rabe, K. G., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0799-8 · Cited by 54
Differential diagnosis in chronic lymphocytic leukaemia
Matutes, E., Wotherspoon, A. C., & Catovsky, D. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2007.03.001 · Cited by 53
BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
Cario, G., Leoni, V., Conter, V., Baruchel, A., Schrappe, M., & Biondi, A. (2020) · Haematologica · doi:10.3324/haematol.2018.207019 · Cited by 53
Shankar, A. G., Kirkwood, A. A., Hall, G. W., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13540 · Cited by 52
Wang, W., & Medeiros, L. J. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.03.003 · Cited by 50
Self-citationHydroa vacciniforme–like lymphoproliferative disorder: Clinicopathologic study of 41 cases
Liu, Y., Ma, C., Wang, G., & Wang, L. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.01.011 · Cited by 48
Criado, I., Rodríguez‐Caballero, A., Gutiérrez, M. L., Pedreira, C. E., Alcoceba, M., Nieto, W. G., Teodósio, C., Bárcena, P., Romero, A. E., Fernández-Navarro, P., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.183954 · Cited by 47
Piña‐Oviedo, S., Ortíz-Hidalgo, C., Carballo-Zarate, A. A., & Zárate‐Osorno, A. (2021) · Cancers · doi:10.3390/cancers13184667 · Cited by 46
Fitzpatrick, M. J., Massoth, L. R., Marcus, C. B., Vergilio, J., Severson, E. A., Duncan, D. L., Ramkissoon, S. H., Hasserjian, R. P., Kim, A. S., Sohani, A. R., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001708 · Cited by 45
Self-citationImpact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
Rimsza, L. M., Li, H., Braziel, R. M., Spier, C. M., Persky, D. O., Dunlap, J. B., LeBlanc, M. L., Bartlett, N. L., Leonard, J. P., Smith, S. M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.175059 · Cited by 44
Liang, H.-C., Costanza, M., Prutsch, N., Zimmerman, M. W., Gurnhofer, E., Montes-Mojarro, I. A., Abraham, B. J., Prokoph, N., Stoiber, S., Tangermann, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25379-9 · Cited by 44
Self-citationJiao, W., Ji, J., Xu, W., Bu, W., Zheng, Y., Ma, A., Zhao, B., & Fan, Q. (2019) · Scientific Reports · doi:10.1038/s41598-019-51603-0 · Cited by 41
Laurent, C., Adélaı̈de, J., Guillé, A., Tesson, B. M., Gat, E., Evrard, S., Escudié, F., Syrykh, C., Canioni, D., Fabiani, B., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001726 · Cited by 40
Self-citationGarcia-Barchino, M. J., Sarasquete, M. E., Panizo, C., Morscio, J., Martínez, A., Alcoceba, M., Fresquet, V., González‐Farré, B., Paiva, B., Young, K. H., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5060 · Cited by 38
Self-citationWhitaker, J. A., Parikh, S. A., Shanafelt, T. D., Kay, N. E., Kennedy, R. B., Grill, D. E., Goergen, K. M., Call, T. G., Kendarian, S. S., Ding, W., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.01.001 · Cited by 38
Quesada, A. E., Zhang, Y., Ptashkin, R. N., Ho, C., Horwitz, S. M., Benayed, R., Doǧan, A., & Arcila, M. E. (2021) · The Breast Journal · doi:10.1111/tbj.14205 · Cited by 38
Thyroid MALT lymphoma: self-harm to gain potential T-cell help
Wu, F., Watanabe, N., Tzioni, M., Akarca, A. U., Zhang, C., Li, Y., Chen, Z., Cucco, F., Carmell, N., Noh, J. Y., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01289-z · Cited by 36
Self-citationVarettoni, M., Boveri, E., Zibellini, S., Tedeschi, A., Candido, C., Ferretti, V. V., Rizzo, E., Doni, E., Merli, M., Farina, L., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25600 · Cited by 35
Fitzsimmons, L., Boyce, A. J., Wei, W., Chang, C. W. T., Croom-Carter, D. S. G., Tierney, R. J., Herold, M. J., Bell, A. I., Strasser, A., Kelly, G. L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.150 · Cited by 33
Muchtar, E., Koehler, A. B., Johnson, M. J., Rabe, K. G., Ding, W., Call, T. G., Leis, J. F., Kenderian, S. S., Hayman, S. R., Wang, Y., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26388 · Cited by 33
G‐banding and molecular cytogenetic analyses of marginal zone lymphoma
Aamot, H. V., Micci, F., Holte, H., Delabie, J., & Heim, S. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05706.x · Cited by 32
The exomic landscape of t(14;18)‐negative diffuse follicular lymphoma with 1p36 deletion
Zamò, A., Pischimarov, J., Horn, H., Ott, G., Rosenwald, A., & Leich, E. (2017) · British Journal of Haematology · doi:10.1111/bjh.15041 · Cited by 30
Self-citationInter-reader variability in follicular lymphoma grading: Conventional and digital reading
Lozanski, G., Pennell, M. L., Shana’ah, A., Zhao, W., Gewirtz, A. S., Racke, F. K., Hsi, E. D., Simpson, S., Mosse, C. A., Alam, S., et al. (2013) · Journal of Pathology Informatics · doi:10.4103/2153-3539.120747 · Cited by 29
Ravindran, A., Feldman, A. L., Ketterling, R. P., Dasari, S., Rech, K. L., McPhail, E. D., Kurtin, P. J., & Shi, M. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001614 · Cited by 29
Self-citationKorona, B., Korona, D., Zhao, W., Wotherspoon, A. C., & Du, M. (2021) · Blood · doi:10.1182/blood.2020010495 · Cited by 29
Self-citationEpstein–Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes
Leoncini, L. (2021) · British Journal of Haematology · doi:10.1111/bjh.17922 · Cited by 29
Self-citationPhiladelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.
Wells, J. E., Jain, N., & Konopleva, M. Y. (2017) · PubMed · Cited by 25
In situ neoplasia in lymph node pathology
Oishi, N., Montes‐Moreno, S., & Feldman, A. L. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.11.001 · Cited by 25
Self-citationClonal B-cell lymphocytosis of marginal zone origin
Xochelli, A., Oscier, D. G., & Σταματόπουλος, Κ. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.08.028 · Cited by 24
RHOA mutation in follicular T‐cell lymphoma: Clinicopathological analysis of 16 cases
Miyoshi, H., Sakata‐Yanagimoto, M., Shimono, J., Yoshida, N., Hattori, K., Arakawa, F., Yanagida, E., Takeuchi, M., Yamada, K., Suzuki, T., et al. (2020) · Pathology International · doi:10.1111/pin.12981 · Cited by 24
Greenough, A., & Davé, S. S. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000059 · Cited by 23
Pham, R. N., Gooley, T. A., Keeney, G. E., Press, O. W., Pagel, J. M., Greisman, H. A., Bensinger, W., Holmberg, L., Petersdorf, S. H., Maloney, D. G., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705864 · Cited by 18
Krijgsman, O., Gonzalez, P., Ponz, O. B., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.085118 · Cited by 15
Ebied, A., Huan, V. T., Makram, O. M., Sang, T. K., Ghorab, M. M. E., Ngo, H. T., Iraqi, A., Kamel, M. G., Đăng, T. N., Vuong, N. L., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1280 · Cited by 14
Numerous Ontogenetic Roads to Mantle Cell Lymphoma
Pouliou, E., Xochelli, A., Kanellis, G., Stalika, E., Sutton, L., Navarro, A., Agathangelidis, A., Dimosthenous, K., Anagnostopoulos, Α., Patsouris, E., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.02.017 · Cited by 12
Advances in the Treatment of Hairy Cell Leukemia Variant
Tran, J., Gaulin, C., & Tallman, M. S. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00927-z · Cited by 8
Cited by
Khoury, J. D., Solary, E., Abla, O., Akkari, Y., Alaggio, R., Apperley, J. F., Bejar, R., Berti, E., Busque, L., Chan, J. K. C., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01613-1 · Cited by 4,274
Self-citationWHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Malard, F., Neri, P., Bahlis, N. J., Terpos, E., Moukalled, N., Hungria, V. T. M., Manier, S., & Mohty, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00529-7 · Cited by 337
A blueprint for tumor-infiltrating B cells across human cancers
Ma, J., Wu, Y., Ma, L., Yang, X., Zhang, T., Song, G., Li, T., Gao, K., Shen, X., Lin, J., et al. (2024) · Science · doi:10.1126/science.adj4857 · Cited by 255
Metadata
- Authors
- Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. D. O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., Chadburn, A., Chan, J. K. C., Cheuk, W., Chng, W.-J., Choi, J. K., Chuang, S.-S., Coupland, S. E., Czader, M., Dave, S. S., de Jong, D., Du, M.-Q., Elenitoba-Johnson, K. S., Ferry, J., Geyer, J., Gratzinger, D., Guitart, J., Gujral, S., Harris, M., Harrison, C. J., Hartmann, S., Hochhaus, A., Jansen, P. M., Karube, K., Kempf, W., Khoury, J., Kimura, H., Klapper, W., Kovach, A. E., Kumar, S., Lazar, A. J., Lazzi, S., Leoncini, L., Leung, N., Leventaki, V., Li, X.-Q., Lim, M. S., Liu, W.-P., Louissaint, A., Marcogliese, A., Medeiros, L. J., Michal, M., Miranda, R. N., Mitteldorf, C., Montes-Moreno, S., Morice, W., Nardi, V., Naresh, K. N., Natkunam, Y., Ng, S.-B., Oschlies, I., Ott, G., Parrens, M., Pulitzer, M., Rajkumar, S. V., Rawstron, A. C., Rech, K., Rosenwald, A., Said, J., Sarkozy, C., Sayed, S., Saygin, C., Schuh, A., Sewell, W., Siebert, R., Sohani, A. R., Tooze, R., Traverse-Glehen, A., Vega, F., Vergier, B., Wechalekar, A. D., Wood, B., Xerri, L., & Xiao, W.
- Venue
- Leukemia
- Published
- 2022-06-22
- Volume
- 36
- Issue
- 7
- Pages
- 1720-1748
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W4283381496
- Cited by
- 4,004
- References
- 200
- FWCI
- 444.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.